Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Etrasimod by Pfizer for Crohn's Disease (Regional Enteritis): Likelihood of Approval
Etrasimod is under clinical development by Pfizer and currently in Phase III for Crohn's Disease (Regional Enteritis). According to GlobalData,...
Etrasimod by Pfizer for Eosinophilic Esophagitis: Likelihood of Approval
Etrasimod is under clinical development by Pfizer and currently in Phase II for Eosinophilic Esophagitis. According to GlobalData, Phase II...
Etrasimod by Pfizer for Eosinophilic Esophagitis: Likelihood of Approval
Etrasimod is under clinical development by Pfizer and currently in Phase II for Eosinophilic Esophagitis. According to GlobalData, Phase II...